Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
Key Highlights
- ➤Carlsmed launches aprevo Lumbar Bi-lateral Posterior System commercially in the U.S.
- ➤First in-human procedure completed February 10, 2026, after limited market evaluation began.
- ➤Bi-lateral System enables direct posterior approach for personalized spine fusion.
- ➤System combines AI-enabled software with surgeon-specific plans and patient-specific fusion devices.
Expert Statements
Mike Cordonnier, Chairman and CEO of Carlsmed
“The launch of the Bi-lateral System further expands our proprietary technology platform to enable a direct posterior approach for personalized spine fusion”
Dr. CJ Kleck, University of Colorado
“Since its initial release, aprevo has established itself as a valuable tool in my surgical armamentarium, allowing me to achieve a new level of patient specificity in my procedures”
Dr. Joshua Bakhsheshian, Mayo Clinic
“I see great potential in this system for patients who may benefit from a posterior approach”
CARLSBAD, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the U.S. commercial launch of its aprevo(®) Lumbar Bi-lateral Posterior System at the North American Spine Society’s 41(st) Annual Meeting (NASS) in San Antonio, TX. The launch follows a limited market evaluation that commenced in February 2026, with the first in human procedure completed on February 10, 2026.
“The launch of the Bi-lateral System further expands our proprietary technology platform to enable a direct posterior approach for personalized spine fusion,” said Mike Cordonnier, Chairman and CEO of Carlsmed. “The Bi-lateral System is optimized to support planned three-dimensional correction of the spine with maximal surface area contact.”
Get started
Create a free account to read the full story.